Gland Pharma’s Pashamylaram facility has received GMP compliance certification from the Danish Medicines Agency for aseptically prepared powder products. Shares of Gland Pharma Ltd ended at ₹1,857.90, up by ₹15.30, or 0.83%, on the BSE.
Gland Pharma’s Pashamylaram facility has received GMP compliance certification from the Danish Medicines Agency for aseptically prepared powder products. Shares of Gland Pharma Ltd ended at ₹1,857.90, up by ₹15.30, or 0.83%, on the BSE.